XML 22 R10.htm IDEA: XBRL DOCUMENT v3.4.0.3
Stock-Based Compensation Expense
3 Months Ended
Mar. 31, 2016
Disclosure of Compensation Related Costs, Share-based Payments [Abstract]  
Stock-Based Compensation Expense

Note 5. Stock-Based Compensation Expense

 

  (a) General

Stock-based compensation expense for restricted stock, restricted stock units, stock options and issuances of common stock pursuant to our employee stock purchase plan was classified in the accompanying consolidated statements of operations as follows:

 

     Three Months Ended March 31,  
     2016      2015  
     (in thousands)  

Stock-based compensation expense:

     

Cost of revenue

   $ 137       $ 49   

Research and development

     1,493         144   

Sales and marketing

     2,901         115   

General and administrative

     988         267   
  

 

 

    

 

 

 

Total stock-based compensation expense

   $ 5,519       $ 575   
  

 

 

    

 

 

 

We recognize compensation cost of all awards on a straight-line basis over the applicable vesting period, which is generally four years.

 

  (b) Restricted Stock and Restricted Stock Units

Restricted stock and restricted stock unit activity during the three months ended March 31, 2016 was as follows:

 

     Restricted Stock      Weighted
Average
Grant Date

Fair Value
 

Outstanding as of December 31, 2015

     1,149,257       $ 19.34   

Granted

     528,550         12.97   

Vested

     (84,649      19.14   

Forfeited

     (32,290      13.61   
  

 

 

    

Outstanding as of March 31, 2016

     1,560,868       $ 17.31   
  

 

 

    

As of March 31, 2016, the unrecognized compensation expense related to our unvested restricted stock and restricted stock units expected to vest was $16.8 million. This unrecognized compensation expense will be recognized over an estimated weighted-average amortization period of 2.8 years.

 

  (c) Stock Options

Stock option activity during the three months ended March 31, 2016 was as follows:

 

     Shares      Weighted
Average
Exercise
Price
     Weighted
Average
Remaining
Contractual Life
(in years)
     Aggregate
Intrinsic
Value
(in thousands)
 

Outstanding as of December 31, 2015

     4,246,525       $ 5.99         

Granted

     916,558         12.96         

Exercised

     (122,284      4.13         

Forfeited/cancelled

     (159,444      10.11         
  

 

 

          

Outstanding as of March 31, 2016

     4,881,355         7.21         7.6       $ 29,337   
  

 

 

          

Vested and exercisable as of March 31, 2016

     2,793,056         4.53         6.6       $ 23,891   

Vested and expected to vest as of March 31, 2016

     4,460,388         6.78         7.4       $ 28,639   

 

As of March 31, 2016, the unrecognized compensation expense related to our unvested stock options expected to vest was $7.7 million. This unrecognized compensation expense will be recognized over an estimated weighted-average amortization period of 2.9 years.

The total fair value of stock options vested in the three months ended March 31, 2016 was $2.3 million. The weighted-average grant date fair value of stock options granted in the three months ended March 31, 2016 was $6.18 per share.

 

  (d) Employee Stock Purchase Plan

Under the 2015 Employee Stock Purchase Plan (ESPP), employees may set aside up to 15% of their gross earnings, on an after-tax basis, to purchase our common shares at a discounted price, which is calculated at 85% of the lesser of: (i) the market value of our common stock at the beginning of each offering period and (ii) the market value of our common stock on the applicable purchase date.

On March 15, 2016 we issued 192,676 shares of common stock to employees for aggregate proceeds of $2.1 million. The purchase price of the shares of common stock was $10.88 per share, which was discounted from the market price of $12.80 at the close of business on March 15, 2016, in accordance with the terms of the ESPP.